돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 436생성일: 2026년 10월 23일

1-Bromo-4-iodobenzene → 1-(4-Bromophenyl)-cis-3,5-dimethylpiperazine

https://huagongshe.com/ko/reaction/436

반응식

참여 물질

역할이름HCID투입량
반응물1-Bromo-4-iodobenzeneHCID 11522—
반응물rel-(2R,6S)-2,6-dimethylpiperazineHCID 6950261—
시약Sodium t-butoxideHCID 23676156—
촉매1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
촉매Palladium (II) acetateHCID 4144353—
용매1,4-DioxaneHCID 31275—
생성물1-(4-Bromophenyl)-cis-3,5-dimethylpiperazineHCID 6673036144.14%

반응 조건

온도90 °C

반응 단계

sodium 2-methylpropan-2-olate (0.510 g, 5.30 mmol) was added to (2R,6S)-2,6-dimethylpiperazine (0.605 g, 5.30 mmol) in dioxane (40 mL) at 21°C under nitrogen. Stirred for 5 mins. 1-bromo-4-iodobenzene (1 g, 3.53 mmol) added, followed by diacetoxypalladium (0.079 g, 0.35 mmol) and (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (0.409 g, 0.71 mmol). Reaction evacuated and refilled with nitrogen several times. Heated at 90C for 18hours. left to cool o/w. The reaction mixture was diluted with EtOAc (250 mL), and washed sequentially with water (150 mL). The organic layer was dried over Na2SO4, filtered and evaporated to afford crude product. The crude product was purified by flash silica chromatography, elution gradient 0 to 30% MeOH in EtOAc. Pure fractions were evaporated to dryness to afford (3S,5R)-1-(4-bromophenyl)-3,5-dimethylpiperazine (0.420 g, 44.1 %) as a yellow solid.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-609b92e7f381461a936ff9653aaca797
출처 메모750 AstraZeneca ELN dataset